• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

Merck Layoffs Reveal Fundamental Problems

Quote








Anonymous said:
http://www.philly.com/philly/blogs/healthcare/Merck-layoffs-reveal-fundamental-problems.html
Click to expand...

Seriously, what do people expect. The idea that novel, outside the box thinking is needed for companies to drive innovation should implemented from top to bottom. Innovation should is not restricted to R&D but rather a way of thinking that should be applied to the entire company. This article aptly points out that there is no creativity going on in the head office. Frazier is just another sheep. Merck management must think everybody else is just too stupid or simply can't remember what was said what leadership said previously. Fortunately the internet has excellent recall. It might take a couple of news cycles for the press to realize what every Merck employee already understands, we are in the middle of a hail-mary pass. Merck management doesn't have a short-term plan let alone a vision for this company's future. That is why every time they talk about it sounds different from the previous time. Public enlightenment into the buffoonery at the highest levels of this organization will be realized as an inconsistent message from the top exposures how inept this management is. In time, even the analysts that demanded these changes will realize their own foolishness and will simply abandon this stock, despite the competitive dividend. MRK will hit $40 before it ever sees $55.
 




I resigned on my own this year after 15 years with this company for the reasons above. It sickens me what leadership has done to this once great company. Merck was THE ONLY company I wanted to work for years ago. This company has been like a boat without a captain. No leadership, and the great leaders we did have at one time have been run off or fired. Those who spoke up are long gone. We have cut R & D until there is nothing left (and BTW, I thought we were once a company based on science-I think you need R & D to lead you that way). The only people left are those who cannot leave. Either they are too close to retirement or cannot find another job somewhere else or are just lazy. I check back every now and then since I still have stock and a pension (one hopes) with this company. I wish everyone who is still there luck, because you are going to need it-either you are going to be let go or you have to face the sad fact that you are still working for this sham of a company. The ones who should be fired are at the top, but again, that is the problem.
 




That article is nothing but an opinion from one person. Just because some of you agree with it, doesn't mean that it is valid. All it proves is that you agree with that person's opinion - nothing else. Get back to your pre-call planning for tomorrow and don't forget the conference call at 8:30 a.m.
 




Anonymous said:
That article is nothing but an opinion from one person. Just because some of you agree with it, doesn't mean that it is valid. All it proves is that you agree with that person's opinion - nothing else. Get back to your pre-call planning for tomorrow and don't forget the conference call at 8:30 a.m.
Click to expand...

Clearly, you have no understanding of Wall Street and are dying from a Kool-Aide OD
 




Anonymous said:
http://www.philly.com/philly/blogs/healthcare/Merck-layoffs-reveal-fundamental-problems.html
Click to expand...

Fundamental problems alright. But not all of the players in the industry seem to be so stuck. If I understand this business in some way. Leadership decides where to focus the efforts to develop products. R&D discovers compounds and gets drugs approved, manufacturing makes the product to sell and M&S sell the product to generate revenue.

Roche has to now scale up the manufacturing process because they have so many biological products nearing the point of sales that they don't have the capacity to make them. I guess sales and revenue or next on the to do list.

http://finance.yahoo.com/news/roche...-055948800.html;_ylt=A2KLOzJzKFxSqDYAqH_QtDMD

Merck management on the other hand, is deciding what we need to do and think biologics may be a lucrative market. Reduce R&D to focus efforts. Cut back on manufacturing because we don't have enough products to keep them busy. Reduce sales and marketing because there is little to sell.

The problems are indeed fundamental but it's not that Merck is caught up in a situation derived from outside forces beyond our control. It that were so, such an article on Roche would not be making the news. If we can weather the storm we will be alright. The storm is not the global environment, it's the executive suite and the BoD. If shareholders want more for their investment then the situation requires a remedy at step one - Merck management and I'm not talking about EC+1, +2 and +3. The EC wants you to believe that moving those deck chairs rights the boat. Where are the activist shareholders that are just tired of the same old...same old?
 








Anonymous said:
Excellent commentary that pretty much sums it up - sees through the KF bullshit and tells the truth
Click to expand...

Ouch!! A savage indictment of Frazier and his lies...

Why any stockholder would hold even one share of this train wreck is beyond me, but I guess many keep it because it pays a dividend...

Oh...by the way...FU MERCK!
 




Top Bottom
Back
Quote